| Tracheal and airway disorders | Lifetime | 3 | GB 1 | 99.92 |
| Neonatal Respiratory Health Research | Lifetime | 8 | GB 1 | 99.91 |
| Cystic Fibrosis Research Advances | Lifetime | 4 | GB 1 | 99.89 |
| Asthma and respiratory diseases | Lifetime | 29 | GB 8 | 99.88 |
| Congenital Diaphragmatic Hernia Studies | Lifetime | 13 | GB 2 | 99.79 |
| Pediatric health and respiratory diseases | Lifetime | 11 | GB 4 | 99.84 |
| Respiratory and Cough-Related Research | Lifetime | 13 | GB 5 | 99.88 |
| Chronic Obstructive Pulmonary Disease (COPD) Research | Lifetime | 33 | GB 6 | 99.80 |
| Inhalation and Respiratory Drug Delivery | Lifetime | 28 | GB 3 | 99.59 |
| Medical Imaging and Pathology Studies | Lifetime | 101 | GB 11 | 99.21 |
| Respiratory viral infections research | Lifetime | 127 | GB 13 | 99.40 |
| Respiratory Support and Mechanisms | Lifetime | 275 | GB 25 | 99.18 |
| Pulmonary Hypertension Research and Treatments | Lifetime | 261 | GB 28 | 98.60 |
| Child and Adolescent Health | Lifetime | 186 | GB 33 | 97.93 |
| Pharmaceutical studies and practices | Lifetime | 270 | GB 25 | 97.70 |
| Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis | Lifetime | 360 | GB 26 | 98.02 |
| Congenital Heart Disease Studies | Lifetime | 552 | GB 42 | 97.96 |
| Genetic and Kidney Cyst Diseases | Lifetime | 189 | GB 15 | 97.02 |
| IL-33, ST2, and ILC Pathways | Lifetime | 266 | GB 27 | 97.35 |
| Neuroscience of respiration and sleep | Lifetime | 751 | GB 51 | 97.27 |
| Pleural and Pulmonary Diseases | Lifetime | 467 | GB 42 | 96.37 |
| Airway Management and Intubation Techniques | Lifetime | 685 | GB 59 | 96.22 |
| Eosinophilic Esophagitis | Lifetime | 746 | GB 57 | 96.61 |
| Ethics and Legal Issues in Pediatric Healthcare | Lifetime | 331 | GB 56 | 93.69 |
| Sleep and related disorders | Lifetime | 911 | GB 54 | 94.92 |
| Ultrasound in Clinical Applications | Lifetime | 606 | GB 33 | 93.85 |
| Delphi Technique in Research | Lifetime | 894 | GB 233 | 86.07 |
| Congenital Ear and Nasal Anomalies | Lifetime | 463 | GB 38 | 85.55 |
| Vascular Anomalies and Treatments | Lifetime | 711 | GB 56 | 85.61 |
| Youth Substance Use and School Attendance | Lifetime | 605 | GB 48 | 80.66 |
| Neonatal Respiratory Health Research | 2021-2025 | 19 | GB 3 | 99.36 |
| Asthma and respiratory diseases | 2021-2025 | 55 | GB 10 | 99.29 |
| Chronic Obstructive Pulmonary Disease (COPD) Research | 2021-2025 | 55 | GB 12 | 98.99 |
| Pediatric health and respiratory diseases | 2021-2025 | 19 | GB 9 | 98.24 |
| Inhalation and Respiratory Drug Delivery | 2021-2025 | 21 | GB 5 | 98.35 |
| Respiratory and Cough-Related Research | 2021-2025 | 39 | GB 12 | 98.60 |
| Pharmaceutical studies and practices | 2021-2025 | 66 | GB 6 | 94.82 |
| Cystic Fibrosis Research Advances | 2021-2025 | 102 | GB 16 | 96.82 |
| Congenital Diaphragmatic Hernia Studies | 2021-2025 | 109 | GB 7 | 95.30 |
| Respiratory Support and Mechanisms | 2021-2025 | 434 | GB 38 | 95.40 |
| Respiratory viral infections research | 2021-2025 | 587 | GB 33 | 91.65 |
| Tracheal and airway disorders | 2021-2025 | 583 | GB 42 | 90.30 |
| Medical Imaging and Pathology Studies | 2021-2025 | 505 | GB 27 | 81.48 |
| Eosinophilic Esophagitis | 2021-2025 | 836 | GB 54 | 84.43 |
| IL-33, ST2, and ILC Pathways | 2021-2025 | 626 | GB 38 | 79.39 |
| Child and Adolescent Health | 2021-2025 | 688 | GB 97 | 73.85 |